Previous work using immunohistochemistry has shown that the expression of FOXA1 [10,31,33] and of GATA-3 [9,34,37] is in close association with ERα expression in breast cancer, highlighting their prognostic and predictive value in this malignancy. Here, FOXA1 is linked to breast cancer.